Skip to content
Search

Latest Stories

GPhC appoints two new Chief officers

The pharmacy regulator has welcomed two new executive officers to achieve next steps in their ‘strategic’ plans

The General Pharmaceutical Council (GPhC) recently appointed a chief pharmacy officer and a chief enforcement officer on 26 October.


Roz Gittins will be joining as chief pharmacy officer and deputy registrar whereas Dionne Spence as chief enforcement officer and deputy registrar from 3 January.

The regulator confirmed that the new officers will “form the new executive structure of the GPhC”.

They will be working with the existing staff members Mark Voce, in his new role, is the chief strategy officer and deputy registrar and Jonathan Bennetts, will be the chief operating officer & deputy registrar.

It is stated that Gittins is to serve as "the most senior member of the profession," offering pharmacy leadership throughout the GPhC.

She will be tasked with "representing the pharmacy regulator authoritatively on professional issues in public."

In her role as the chief pharmacy officer, Gittins will provide comprehensive professional leadership within the GPhC, collaborating closely with the company's pharmacists and pharmacy technicians.

She said: "I’m looking forward to joining the GPhC team in the new year. As a registrant, I know how important it is for our regulator to connect more effectively with pharmacists and pharmacy technicians.

“I hope that this new role, alongside Dionne and other GPhC colleagues, offers a unique opportunity to influence progress, at an exciting and challenging time for the pharmacy professions."

Meanwhile, Dionne Spence will be overseeing and enhancing Fitness to Practise (FIT) processes and enforcement actions against registered pharmacies.

She will promote a consistent strategic and cultural approach to fitness to practice and pharmacy enforcement.

Talking about the company, Spence said: "I am delighted to be joining the GPhC, my second healthcare regulator, in this new and exciting role, and at such a critical time for the pharmacy professions.

“Coming in at the inception of this innovative approach to leadership, with a team so committed to streamlining our regulatory functions and improving the service provided to all users is incredibly exciting and will provide great benefit to the sector.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less